157 filings
Page 6 of 8
8-K
6hmdaftlw9fp pufb8g
28 May 20
Departure of Directors or Certain Officers
4:12pm
DEFA14A
m7rtn
22 May 20
Additional proxy soliciting materials
8:06am
8-K
idcm28vt2vwyibe18z1
11 May 20
Castle Biosciences Announces First Quarter 2020 Results
4:09pm
DEFA14A
bnpwkszq04 gb
23 Apr 20
Additional proxy soliciting materials
11:02am
DEF 14A
vwbkq6ihwzgq4
23 Apr 20
Definitive proxy
11:00am
8-K
9cagia25qj spotyq07
15 Apr 20
Regulation FD Disclosure
7:59am
8-K
2otzsin zk7tpn12pn
1 Apr 20
Departure of Directors or Certain Officers
5:09pm
S-8
wctisnrdws2oiciq 70
10 Mar 20
Registration of securities for employees
5:00pm
10-K
8f3247u3erugxswur
10 Mar 20
Annual report
4:51pm
8-K
wgd6j
10 Mar 20
Castle Biosciences Announces Fourth Quarter and Full-Year 2019 Results
4:11pm
8-K
aminzxtuwxxr
5 Mar 20
Entry into a Material Definitive Agreement
4:15pm
8-K
hiduwswhlutjkd57frb
9 Jan 20
Q4 2019 DecisionDx-Melanoma test report volume increased 37% compared to Q4 2018
5:03pm
8-K
3jeg6e7g07zbc3a2tlx2
19 Dec 19
Entry into a Material Definitive Agreement
4:45pm
8-K
a91fevp 3g32gnzkct
14 Nov 19
Results of Operations and Financial Condition
5:01pm
8-K
uu1rrlps9jix3
12 Nov 19
Castle Biosciences Reports Third Quarter 2019 Results
6:19am
10-Q
rpqwm x7ff
3 Sep 19
Quarterly report
4:13pm
8-K
zgjelchdoie
3 Sep 19
Castle Biosciences Reports Second Quarter 2019 Results
4:09pm
D
9035t y56l52
30 Jul 19
$20M in debt / options / securities to be acquired, sold $10M, 1 investor
12:00am